Attovia Therapeutics (ATTO) vs 4D Molecular Therapeutics (FDMT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Attovia Therapeutics is the larger company by market cap ($749.6 million vs $695.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATTO | FDMT |
|---|---|---|
| Share price | $16.42 | $12.59 |
| Market cap | $749.59M | $695.52M |
| 1-day change | -6.17% | +0.24% |
| 5-year return | — | -53.92% |
| EPS (TTM) | $-2.74 | $-2.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.00 | $16.93 |
| 52-week low | $16.15 | $6.96 |
| Distance from 52-week high | -41.36% | -25.63% |
| Average volume | 456.94K | 924.05K |
| Shares outstanding | 45.65M | 55.24M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ATTO vs FDMT FAQ
Which is bigger, Attovia Therapeutics or 4D Molecular Therapeutics?
Attovia Therapeutics (ATTO) is larger, with a market capitalization of $749.59M compared with $695.52M for 4D Molecular Therapeutics (FDMT).
Are Attovia Therapeutics and 4D Molecular Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.